ICS 2020 Scientific Open Discussion Session S4

ePoster 1

Professional interest
	Scientific Open Discussion Session S4
	Lunch provided
	On-Demand
Urology Urogynaecology and Female & Functional Urology Bowel Dysfunction Pure and Applied Science Conservative Management

Session Schedule

#31 Effect of phosphodiesterase type 5 inhibitor tadalafil on prostatic enlargement in spontaneously hypertensive rat

Presenter: Shogo Shimizu

Shimizu S¹, Nagao Y¹, Shimizu T¹, Kataoka T¹, Kamada S¹, Okamoto R¹, Higashi Y¹, Aratake T¹, Zou S¹, Hamada T¹, Yamamoto M¹, Saito M¹
1. Department of Pharmacology, Kochi Medical School, Kochi University, Nankoku, Japan
Benign Prostatic Hyperplasia (BPH), Pharmacology, Pathophysiology
ePoster Station 1

#32 THE EFFECTS OF CLINICAL CARE PATHWAY USE AND NOVEL DEVICES ON THIRD LINE THERAPY PENETRATION RATES IN A CONTEMPORARY PRACTICE

Presenter: Alexandra Rogers

Rogers A¹, Bertrando N¹
1. Sansum Clinic
Overactive Bladder, Voiding Dysfunction , Urgency Urinary Incontinence, New Devices, Urgency/Frequency
ePoster Station 1

#33 Once-Daily Vibegron 75 mg for Overactive Bladder: Double-Blind 52-Week Results From an Extension Study of the International Phase 3 Trial (EMPOWUR)

Presenter: David Staskin

Staskin D¹, Frankel J², Varano S³, Shortino D⁴, Jankowich R⁴, Mudd Jr P⁴
1. Tufts University School of Medicine, Boston, MA, 2. Seattle Urology Research Center, Seattle, WA, 3. Clinical Research Consulting, Milford, CT, 4. Urovant Sciences, Irvine, CA
Overactive Bladder, Incontinence, Quality of Life (QoL), Urgency/Frequency, Voiding Dysfunction
ePoster Station 1

#34 Deletion of the lysyl oxidase-like 1 gene induces impaired elastin fiber synthesis and inefficient urethral closure in rats

Presenter: Katsumi Kadekawa

Kadekawa K¹, Nishijima S¹, Noguchi K¹, Okitsu S², Matsuzaki T³, Karube K⁴, Matsumoto S⁵, Yamamoto H², Sugaya K¹
1. Southern Knights' Laboratory, 2. Departments of biochemistry, University of the Ryukyus, 3. Department of pharmacology, University of the Ryukyus, 4. Departments of pathology and cell biology, University of the Ryukyus, 5. Center for advanced research and education, Asahikawa medical university
Stress Urinary Incontinence, Pelvic Organ Prolapse, Basic Science
ePoster Station 1

#35 Urologic Hospitalizations In Contemporary Cohort of SCI Patients

Presenter: Irene Crescenze

Crescenze I¹, Lenherr S², Myers J², Elliott S³, Welk B⁴, O'Dell D⁵, Stoffel J⁵
1. Ohio State University, 2. University of Utah, 3. University of Minnesota, 4. Western University, 5. University of Michigan
Spinal Cord Injury, Infection, Urinary Tract, Prospective Study, Rehabilitation
ePoster Station 1

#36 Comparative study of therapeutic efficacy and safety between mirabegron 50mg QD and solifenacin 5mg QD in patients with overactive bladder due to central nervous system diseases such as cerebral vascular accident, Parkinson’s disease, and dementia – A multicenter, randomized study

Presenter: Chun-Hou Liao

Liao C¹, Chen S², Lee C², Jhang J², Jiang Y², Kuo H²
1. Department of Urology, Cardinal Tien Hospital and School of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan, 2. Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
Pharmacology, Incontinence, Neuropathies: Central
ePoster Station 2

#37 A supervised test phase in sacral neuromodulation with medium-term results after a one-year follow-up

Presenter: Sam Tilborghs

Tilborghs S¹, Van de Borne S¹, Vaganée D¹, De Win G¹, de Wachter S¹
1. Department of Urology, University Hospital Antwerp, Edegem, Belgium
Neuromodulation, Voiding Dysfunction , Urgency Urinary Incontinence, Prospective Study
ePoster Station 2

#38 Urinary evaluations of decompression surgery for cervical myelopathy and lumbar canal stenosis

Presenter: Shingo Kimura

Kimura S¹, Takyu S², Hayashi N¹, Kawamorita N¹, Morozumi N³, Ito A¹
1. Tohoku University Department of Urology, 2. Sendai Nishitaga Hospital Department of Urology, 3. Sendai Nishitaga Hospital Department of Orthopedics
Neuropathies: Central, Overactive Bladder, Underactive Bladder
ePoster Station 2

#39 Is EDSS enough to predict risk of upper urinary tract damage in patients with multiple sclerosis?

Presenter: Kevin Stritt

Stritt K¹, Silvia M¹, Lucca I¹, Schurch B², Grilo N¹
1. Department of Urology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland, 2. Department of Neurourology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland
Multiple Sclerosis, Voiding Dysfunction , Retrospective Study
ePoster Station 2

#40 ASSOCIATIONS BETWEEN MRI AND URODYNAMIC FINDINGS AMONG MULTIPLE SCLEROSIS PATIENTS WITH URINARY SYMPTOMS

Presenter: John T Stoffel

Sion N¹, Mao Draayer Y², Clemens Q², Gupta P², Barboglio-Romo P², Cameron A², Stoffel J²
1. Central Michigan University School of Medicine, 2. University of Michigan
Multiple Sclerosis, Imaging, Voiding Dysfunction , Quality of Life (QoL), Urodynamics Techniques
ePoster Station 2

#41 Correlation of interstitial cystitis/bladder pain syndrome phenotype based on glomerulations and MBC subgroups and clinical characteristics

Presenter: Yuh-Chen Kuo

Kuo Y¹, Hsu Y², Jhang J³, Lee C³, Chen S³, Jiang Y³, Kuo H³
1. Department of Urology, Yangming Branch of Taipei City Hospital, Taipei, Taiwan, 2. Department of Pathology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan, 3. Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
Painful Bladder Syndrome/Interstitial Cystitis (IC), Pathophysiology, Outcomes Research Methods
ePoster Station 3

#42 The Occurrences of Metabolic Syndrome in Female Patients with and Without Interstitial cystitis/Bladder Pain Syndrome

Presenter: Peng Liao

Liao P¹, De-yi L¹
1. Department of Urology, West China Hospital, Sichuan university, Chengdu, CHINA
Painful Bladder Syndrome/Interstitial Cystitis (IC), Female, Quality of Life (QoL)
ePoster Station 3

#43 Bioinformatic approach for identifying novel biomarkers and their signaling pathways involved in interstitial cystitis/bladder pain syndrome

Presenter: Aram Kim

Kim A¹, Kim H², Han J³, Kim H¹
1. Department of Urology, Konkuk University Medical Center, Konkuk University School of medicine, Seoul, Korea, 2. Dertment of Urology, Eunpyeong St.Mary's Hospital, The Catholic University of Korea, Seoul, Korea, 3. Dertment of Urology, Seongnam Citizens Medical Center, Seongnam City, Korea
Painful Bladder Syndrome/Interstitial Cystitis (IC), Voiding Dysfunction , Pathophysiology
ePoster Station 3

#44 Pelvic pain and retrograde nervous ischiadicus stimulation

Presenter: Paola Nosella

Nosella P¹, Pinciroli L¹, Giacomel G¹
1. San Vito al Tagliamento Hospital
Pain, Pelvic/Perineal, Neuromodulation, Incontinence, Urgency, Fecal, Urgency Urinary Incontinence
ePoster Station 3

#45 Patient perspectives on cannabinoids for interstitial cystitis/bladder pain syndrome

Presenter: Katherine H Anderson

Anderson K¹, Jenkins D², Lynch M¹, Cox A¹
1. Dalhousie University, 2. Queen's University
Painful Bladder Syndrome/Interstitial Cystitis (IC), Quality of Life (QoL), Questionnaire
ePoster Station 3

International Continence Society

ePoster 1

Session Schedule

Comments

Chat